DOCK8 is critical for the survival and function of NKT cells

Blood

Volumn 122, Issue 12, 2013, Pages 2052-2061

  Crawford, Greg ^a   Enders, Anselm ^b   Gileadi, Uzi ^a   Stankovic, Sanda ^c   Zhang, Qian ^d   Lambe, Teresa ^a   Crockford, Tanya L ^a   Lockstone, Helen E ^e   Freeman, Alexandra ^d   Arkwright, Peter D ^f   Smart, Joanne M ^g   Ma, Cindy S ^h   Tangye, Stuart G ^h   Goodnow, Christopher C ^b   Cerundolo, Vincenzo ^a   Godfrey, Dale I ^c   Su, Helen C ^d   Randall, Katrina L ^b,i   Cornall, Richard J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Australian National University   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CD103 ANTIGEN; IMMUNOGLOBULIN E; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; ALPHA E INTEGRINS; ALPHA INTEGRIN; DOCK8 PROTEIN, HUMAN; DOCK8 PROTEIN, MOUSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HERMES ANTIGEN; KLRB1C PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEDICATOR OF CYTOKINESIS 8 DEFICIENCY; DISEASE COURSE; ECZEMA; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SPLEEN CELL; THYMUS; ANIMAL; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LIVER; LYMPHOCYTE COUNT; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, LY; CELL SURVIVAL; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOPHENOTYPING; INTEGRIN ALPHA CHAINS; LIVER; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; THYMUS GLAND;

EID: 84887595223     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-482331     Document Type: Article

References (50)

1. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11(2):131-142.
2. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest. 2004;114(10):1379-1388.
3. Diana J, Lehuen A. NKT cells: friend or foe during viral infections? Eur J Immunol. 2009;39(12):3283-3291.
4. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response tomicroorganisms. Nat Rev Microbiol. 2007;5(6):405-417.
5. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol. 2012;12(4):239-252.
6. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004;4(3):231-237.
7. Stronge VS, Salio M, Jones EY, Cerundolo V. A closer look at CD1d molecules: new horizons in studying NKT cells. Trends Immunol. 2007; 28(10):455-462.
8. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymicNKT cell development. J ExpMed. 2005;202(4):485-492.
9. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol. 2007;7(7):505-518.
10. Berzins SP, McNab FW, Jones CM, Smyth MJ, Godfrey DI. Long-term retention of mature NK1.11 NKT cells in the thymus. J Immunol. 2006;176(7):4059-4065.
11. Das R, Sant' Angelo DB, Nichols KE. Transcriptional control of invariant NKT cell development. Immunol Rev. 2010;238(1):195-215.
12. Allende ML, Zhou D, Kalkofen DN, et al. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J. 2008; 22(1):307-315.
13. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11(3):197-206.
14. McNab FW, Berzins SP, Pellicci DG, Kyparissoudis K, Field K, Smyth MJ, Godfrey DI. The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol. 2005; 175(6):3762-3768.
15. Harada Y, Tanaka Y, Terasawa M, et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012;119(19):4451-4461.
16. Côté J-F, Vuori K. GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends Cell Biol. 2007;17(8):383-393.
17. Meller N, Merlot S, Guda C. CZH proteins: a new family of Rho-GEFs. J Cell Sci. 2005;118(Pt 21): 4937-4946.
18. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046-2055.
19. Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-1302.
20. Chu EY, Freeman AF, Jing H, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148(1):79-84.
21. Kunisaki Y, Tanaka Y, Sanui T, et al. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. J Immunol. 2006;176(8): 4640-4645.
22. Randall KL, Lambe T, Johnson AL, et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol. 2009;10(12):1283-1291.
23. Lambe T, Crawford G, Johnson AL, et al. DOCK8 is essential for T-cell survival and the maintenance of CD81 T-cell memory. Eur J Immunol. 2011;41(12):3423-3435.
24. Randall KL, Chan SS-Y, Ma CS, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208(11): 2305-2320.
25. Schaefer BC, Schaefer ML, Kappler JW, Marrack P, Kedl RM. Observation of antigen-dependent CD81 T-cell/ dendritic cell interactions in vivo. Cell Immunol. 2001;214(2):110-122.
26. Karadimitris A, Gadola S, Altamirano M, et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci USA. 2001;98(6):3294-3298.
27. Emoto M, Mittr ücker HW, Schmits R, Mak TW, Kaufmann SH. Critical role of leukocyte functionassociated antigen-1 in liver accumulation of CD41 NKT cells. J Immunol. 1999;162(9):5094-5098.
28. Thomas SY, Scanlon ST, Griewank KG, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med. 2011;208(6):1179-1188.
29. Gordy LE, Bezbradica JS, Flyak AI, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol. 2011;187(12):6335-6345.
30. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol. 2003;171(6):2960-2969.
31. Gorfu G, Rivera-Nieves J, Ley K. Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med. 2009;9(7):836-850.
32. Doisne J-M, Becourt C, Amniai L, et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t1 and respond preferentially under inflammatory conditions. J Immunol. 2009; 183(3):2142-2149.
33. You J-J, Lin-Chao S. Gas7 functions with NWASP to regulate the neurite outgrowth of hippocampal neurons. J Biol Chem. 2010; 285(15):11652-11666.
34. Quemeneur L, Angeli V, Chopin M, Jessberger R. SWAP-70 deficiency causes high-affinity plasma cell generation despite impaired germinal center formation. Blood. 2008;111(5):2714-2724.
35. Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, Faveeuw C. Role of marginal zone B lymphocytes in invariant NKT cell activation. J Immunol. 2009;182(10):6105-6113.
36. Locci M, Draghici E, Marangoni F, et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med. 2009;206(4):735-742.
37. Astrakhan A, Ochs HD, Rawlings DJ. Wiskott- Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J Immunol. 2009;182(12):7370-7380.
38. Matangkasombut P, Pichavant M, Saez DE, et al. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood. 2008;111(1):271-274.
39. Bassiri H, Janice Yeo WC, Rothman J, Koretzky GA, Nichols KE. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, antitumor and humoral immune responses. Immunol Res. 2008;42(1-3):145-159.
40. Van Dommelen SLH, Degli-Esposti MA. NKT cells and viral immunity. Immunol Cell Biol. 2004;82(3): 332-341.
41. Molling JW, Langius JAE, Langendijk JA, et al. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol. 2007;25(7):862-868.
42. Crowe NY, Coquet JM, Berzins SP, et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med. 2005;202(9):1279-1288.
43. Egawa T, Eberl G, Taniuchi I, et al. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity. 2005;22(6):705-716.
44. Nunez-Cruz S, Yeo WCJ, Rothman J, et al. Differential requirement for the SAP-Fyn interaction during NK T cell development and function. J Immunol. 2008;181(4):2311-2320.
45. Pasquier B, Yin L, Fondaneche M-C, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201(5):695-701.
46. Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature. 2008;455(7214):764-769.
47. Sill é FCM, Martin C, Jayaraman P, et al. Critical role for invariant chain in CD1d-mediated selection and maturation of Va14-invariant NKT cells. Immunol Lett. 2011;139(1-2):33-41.
48. Williams JA, Lumsden JM, Yu X, et al. Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol. 2008;181(2): 907-917.
49. Townsend MJ, Weinmann AS, Matsuda JL, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity. 2004;20(4):477-494.
50. Ohteki T, Maki C, Koyasu S, Mak TW, Ohashi PS. Cutting edge: LFA-1 is required for liver NK1.11 TCR alpha beta1 cell development: evidence that liver NK1.11TCR alpha beta1 cells originate from multiple pathways. J Immunol. 1999;162(7): 3753-3756.